Global Rapid Influenza Diagnostics Market, By Type of Disease (Influenza A, Influenza B), Test Type (STANDARD F Influenza A/B Fluorescence Immunoassay (STANDARD F), Sofia Influenza A + B Fluorescence Immunoassay (Sofia), Immunochromatographic Assay, Real-Time Polymerase Chain Reaction (RT-PCR), Others), End User (Hospitals & Clinics, Laboratories, Other), Distribution Channel (Direct, Retail), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028.
Market Analysis and Insights : Global Rapid Influenza Diagnostics Market
Rapid influenza diagnostics market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to grow at a CAGR of 7.75% in the above-mentioned forecast period. Rise in the government initiatives drives the rapid influenza diagnostics market swiftly.
Rapid influenza diagnostic tests (RIDTs) are the type of immunoassays that identifies the presence of influenza A and B viral nucleoprotein antigens in respiratory specimens. The RIDTs have received attention as it offers advantages over the other methods, for instance rapid result in less than approximately 15 minutes, high specificity and easy performance.
Rise in the geriatric population is the vital factor escalating the market growth, also rise in the advanced technological diagnostic tests, increase in the investments in detection and control of influenza and rise in the research and development activities in the market are the major factors among others driving the rapid influenza diagnostics market. Moreover, rise in the demand from emerging economies will further create opportunities for rapid influenza diagnostics market in the forecasted period of 2021 to 2028.
However, high prices of reagents and kits, rise in the negative results of RIDTs for a tubeless insulin pump and inconsistency in sensitivity and specificity of diagnostic tests are the major factors among others acting act as restraints, and will further challenge the growth of rapid influenza diagnostics market in the forecast period mentioned above.
Rapid influenza diagnostics market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Data Bridge Market Research rapid influenza diagnostics market contact us for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Rapid Influenza Diagnostics Market Scope and Market Size
Rapid influenza diagnostics market is segmented on the basis of type of disease, test type, end-user and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- Based on type of disease, the rapid influenza diagnostics market is segmented into influenza A and influenza B.
- Based on test type, the rapid influenza diagnostics market is segmented into standard f influenza a/b fluorescence immunoassay (standard f), sofia influenza a + b fluorescence immunoassay (sofia), immunochromatographic assay, real-time polymerase chain reaction (rt-pcr) and others.
- Based on end-user, the rapid influenza diagnostics market is segmented into hospitals & clinics, laboratories and other.
- Rapid influenza diagnostics market is also segmented on the basis of distribution channel into direct and retail.
Rapid Influenza Diagnostics Market Country Level Analysis
Rapid influenza diagnostics market is analysed and market size insights and trends are provided by country, type of disease, test type, end-user and distribution channel as referenced above.
The countries covered in the rapid influenza diagnostics market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the rapid influenza diagnostics market due to rise in the advanced technological diagnostic tests, increase in the investments in detection and control of influenza and rise in the research and development activities in this region.
The country section of the rapid influenza diagnostics market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
Rapid influenza diagnostics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for rapid influenza diagnostics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the rapid influenza diagnostics market. The data is available for historic period 2011 to 2019.
Competitive Landscape and Rapid Influenza Diagnostics Market Share Analysis
Rapid influenza diagnostics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to rapid influenza diagnostics market.
The major players covered in the rapid influenza diagnostics market report Abbott, BD, Quidel Corporation., Princeton BioMeditech Corporation, Thermo Fisher Scientific, F. Hoffmann-La Roche Ltd, DiaSorin S.p.A., SA Scientific, Meridian Bioscience, Inc., Analytik Jena AG (Endress+Hauser Management AG), Luminex Corporation and Boryung Co.,Ltd., among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-
